This Article Full Text (PDF) All Versions of this Article: 0269881106061712v1 20/6/789    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (3) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Oranje, B. Articles by Kahn, R. S. Search for Related Content PubMed PubMed Citation Articles by Oranje, B. Articles by Kahn, R. S. Social Bookmarking                         What's this?

No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention

Centre for Neuropsychiatric Schizophrenia Research, Department of Psychiatry, Bispebjerg University Hospital, Copenhagen, Denmark

C. C. Gispen-de Wied

H. G. M. Westenberg

C. Kemner

Department of Psychiatry, University Medical Centre, Utrecht, The Netherlands

M. N. Verbaten

Faculty of Pharmaceutical Sciences, Department of Psychopharmacology, Utrecht University, Utrecht, The Netherlands

R. S. Kahn

Department of Psychiatry, University Medical Centre, Utrecht, The Netherlands

Patients with schizophrenia exhibit diverse cognitive deficits, one of which is a loss of the ability to focus attention. According to the revised dopamine hypothesis of schizophrenia both an increased mesolimbic and a decreased prefrontal dopaminergic activity is suggested to be involved in schizophrenia. The current study was designed to explore the relationship between dopamine and two psychophysiological parameters of selective attention, i.e. P300 amplitude and processing negativity (PN) in healthy volunteers.

In two separate experiments, with a double-blind, balanced and placebo-controlled crossover design, 18 healthy male volunteers were orally administered either 300mg l-dopa (precursor of dopamine) or placebo (experiment I), or 1.25mg bromocriptine (D2 agonist) or placebo (experiment II). Following this treatment they were tested in an auditory, dichotic selective attention paradigm.

An increase in P300 amplitude was found following deviant stimuli when compared to standard stimuli and following attended stimuli when compared to unattended stimuli, regardless of treatment. Similarly, PN was found regardless of treatment. Neither l-dopa nor bromocriptine affected task performance or the amplitudes of PN or P300.

In the present study neither l-dopa nor bromocriptine affected PN, P300 amplitude or task performance in healthy controls, phenomena which are usually found to be disrupted in schizophrenia. This indicates that P300 amplitude and PN are neither affected by a global (l-dopa) increased dopaminergic activity, nor by a more selectively towards striatal areas targeted (bromocriptine) increase in dopaminergic activity.

Key Words: dopamine • l-dopa • bromocriptine • selective attention • P300 • processing negativity • auditory oddball task

This version was published on November 1, 2006

Journal of Psychopharmacology, Vol. 20, No. 6, 789-798 (2006)
DOI: 10.1177/0269881106061712


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?